Johnson Financial Group Inc. reduced its position in shares of CVS Health (NYSE:CVS) by 27.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,583 shares of the pharmacy operator’s stock after selling 7,999 shares during the quarter. Johnson Financial Group Inc.’s holdings in CVS Health were worth $1,565,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CVS. Fieldpoint Private Securities LLC raised its position in CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares in the last quarter. Wealthcare Advisory Partners LLC raised its position in CVS Health by 330.3% during the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares in the last quarter. Arcadia Investment Management Corp MI raised its position in CVS Health by 119.6% during the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares in the last quarter. Cerebellum GP LLC bought a new stake in CVS Health during the fourth quarter worth $130,000. Finally, Capital Analysts LLC raised its position in CVS Health by 240.1% during the fourth quarter. Capital Analysts LLC now owns 3,177 shares of the pharmacy operator’s stock worth $137,000 after acquiring an additional 2,243 shares in the last quarter. 83.97% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

In related news, EVP Helena Foulkes sold 19,965 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the transaction, the executive vice president now directly owns 65,072 shares of the company’s stock, valued at $4,622,714.88. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.61% of the stock is currently owned by company insiders.

Several analysts have issued reports on the stock. Needham & Company LLC raised shares of CVS Health from a “buy” rating to a “strong-buy” rating and upped their price target for the stock from $88.00 to $100.00 in a research report on Tuesday, January 30th. Mizuho set a $95.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Cowen reissued an “outperform” rating and issued a $99.00 price objective (up from $81.00) on shares of CVS Health in a research report on Thursday, January 18th. Vetr lowered shares of CVS Health from a “hold” rating to a “sell” rating and set a $76.66 price objective on the stock. in a research report on Tuesday, January 16th. Finally, ValuEngine lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $86.65.

NYSE:CVS opened at $66.10 on Tuesday. CVS Health has a 52 week low of $60.14 and a 52 week high of $84.00. The stock has a market cap of $64,351.77, a P/E ratio of 11.20, a price-to-earnings-growth ratio of 1.05 and a beta of 1.05. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The business had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. During the same period last year, the firm earned $1.71 earnings per share. CVS Health’s revenue for the quarter was up 5.3% compared to the same quarter last year. equities research analysts anticipate that CVS Health will post 6.3 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 3rd. Investors of record on Monday, April 23rd will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s dividend payout ratio is 33.90%.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/04/17/johnson-financial-group-inc-has-1-57-million-holdings-in-cvs-health-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.